Bioinformatics Market Analysis North America,Europe,Asia,Rest of World (ROW) - US,Canada,Germany,UK,France - Size and Forecast 2023-2027

Published: Oct 2023 Pages: 170 SKU: IRTNTR73655

Bioinformatics Market Forecast 2023-2027

The bioinformatics market size is forecast to increase by USD 8.53 billion at a CAGR (Compound Annual Growth Rate) of 13% between 2022 and 2027. The growth of the market depends on several factors, including the reduction in the cost of genetic sequencing, increasing demand for protein sequencing, and emerging techniques for genome analysis. The advances and the completion of the Human Genome Project (HGP) in 2003 have led to a significant reduction in the cost of genetic sequencing. This market research and growth report also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the market growth analysis report includes historic market data from 2017 to 2021.

What will be the Size of the Bioinformatics Market During the Forecast Period?

To learn more about this report, View Report Sample

The market is propelled by advancements in virus variability analysis, diagnostic methods, and DNA sequencing technologies. Companies like Illumina, Eurofins Scientific, and BGI are pioneering innovations in genomic research, facilitating the development of vaccines and precision medicine solutions. Collaboration between research institutions and healthcare enterprises, such as Brunei’s Ministry of Health and Healthcare Global Enterprises, underscores the global effort to leverage bioinformatics for improved healthcare outcomes.

Market Dynamics and Customer Landscape

The market is witnessing substantial growth, driven by increased investments from both public and private sectors. Precision medicine and genome sequencing advancements are key focal points, with rising demand for genomics instruments and NGS technologies. Emerging markets are embracing bioinformatics for transcriptomics and sequencing applications. Amidst virus variability concerns, computational technology aids in research platforms for transmission chain analysis. Public health entities prioritize containment measures and diagnostic methods, spurring market expansion. Leading players like Illumina, Eurofins Scientific, and BGI play pivotal roles, supported by innovative firms such as NanoString and Strand Life Sciences. Collaboration, exemplified by Brunei’s Ministry of Health, accelerates bioinformatics innovation globally. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

Reduction in the cost of genetic sequencing notably drives the market growth during the forecast period. Advanced genomic sequencing technologies such as NGS have significantly reduced the cost of performing sequential studies and provide high-variant detection power and sensitivity by enabling multiple sequencing. For example, NGS can determine millions of fragments per run and provide cost benefits by avoiding running multiple sequencing cycles. 

The reduced cost increases the propensity of R&D, positively impacting the growth of the global market. Furthermore, factors such as the advent of NGS, deoxyribonucleic acid (DNA) microarray, and CRISPR have brought a paradigm shift in genomic sequencing and editing procedures by enabling targeted and high-throughput sequencing and multiplexing. Hence, such factors drive market growth for during the forecast period.

Significant Market Trends

The development of sophisticated tools for NGS is an emerging bioinformatics market trend influencing market growth. A key tool used for DNA sequencing is Oxford Nanopore MinION, which helps identify virus mutations and track their evolutionary history by enabling real-time, on-site DNA sequencing. 

Furthermore, although DNA sequencing technologies are developing rapidly as well as have increased the availability of robust commercial platforms, analyzing the data obtained through NGS remains an enormous task. Various companies now offer commercial solutions for NGS, which address the issues associated with the scale of analysis and the need for command-line computer languages. Hence, such market trends and analysis boost the market.

Major Market Challenge

A shortage of trained laboratory professionals is a major challenge hindering the growth of the market during the forecast period. Like any other field, the field of medical laboratory science is affected by severe workforce shortages with personnel shortages raising concerns about laboratory staff workload and turnover. Additionally, personnel turnover is also an increasing problem. 

Processes involved require careful application of reagents and handling of apparatus. Moreover, the interpretation of results becomes increasingly important, as well as researchers must be aware of what analysis to conduct and how to correlate it with the overall objective of the experiment. For example, before beginning a protein crystallization experiment, researchers must consider the molecular weight of the protein, the buffer solution required for the experiment, and the stability of the protein. Therefore, such a shortage of trained professionals impedes market growth during the forecast period.

Customer Landscape

The Market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.

Global Market Customer Landscape

Who are the Major Bioinformatics Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

  •  Agilent Technologies Inc.:-  The company offers NGS and CGH data analysis and variant interpretation.

The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

  • Azenta Inc.
  • Bio Rad Laboratories Inc.
  • Biomax Informatics AG
  • DNASTAR Inc.
  • Eurofins Scientific SE
  • Fios Genomics Ltd.
  • Genedata AG
  • Geneva Bioinformatics SA
  • Illumina Inc.
  • Partek Inc.
  • Perkin Elmer Inc.
  • Precigen Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Seven Bridges Genomics Inc.
  • Source BioScience
  • Thermo Fisher Scientific Inc.
  • Waters Corp.
  • ZS Associates Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Segmentation

In the application segment of the market, public and private-sector funding plays a pivotal role in driving advancements. Pharma biotech R&D expenditure continues to fuel innovations, particularly in genome sequencing and transcriptomics research. Despite challenges like equipment costs, NGS technologies and genomics instruments are facilitating breakthroughs in understanding complex biological processes. Emerging markets are increasingly adopting computational technology to study viruses and analyze transmission chains. Research platforms are vital for public health control, enabling the implementation of containment measures and informed decision-making in disease management strategies.

By Application

The market share growth by the molecular phylogenetics segment will be significant during the forecast period. Molecular phylogenetics is a branch that involves the use of molecular data to study the evolutionary relationships among species. This technique revolutionizes the field of biology by providing a more accurate and detailed understanding of the relationships among living organisms. Molecular phylogenetics is an important tool that plays a significant role in many research areas, including drug discovery, disease diagnosis, and conservation biology, in the global  market.

Get a glance at the market contribution of various segments View the PDF Sample

The molecular phylogenetics segment was valued at  USD 3.54 billion in 2017 and continued to grow until 2021. By studying the evolution of proteins and enzymes, researchers can identify potential drug targets and develop more effective drugs with fewer side effects, which has led to the development of new treatments for a wide range of diseases, including cancer, malaria, and HIV. Additionally, molecular phylogenetics is used in many other research areas. Hence, such applications boost the segment growth during the forecast period.

Key Regions

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. A major factor driving the growth of the market in North America is the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases.

It is a leading region in the global market, with a significant market share. The region is driven by the growing demand solutions from research organizations and pharmaceutical companies. The North American region has a well-established healthcare industry, advanced research infrastructure, and many top-tier research universities contributing to regional market growth. 

Market Analyst Overview

The market is witnessing rapid expansion driven by substantial public and private-sector funding and the growing focus on precision medicine. Increased pharma biotech R&D expenditure is fueling advancements in genome sequencing technologies, despite challenges such as high equipment costs. Next-generation sequencing (NGS) technologies and genomics instruments are playing pivotal roles in genomic research, particularly in emerging markets. Bioinformatics tools facilitate the analysis of vast datasets, including transcriptomics data, aiding in understanding diseases caused by viruses and other pathogens. Computational technology and sophisticated research platforms enable the study of virus variability and the development of vaccines and diagnostic methods. Notable players in this market include organizations like BGI, NanoString, and Indivumed GmbH, supported by initiatives such as those led by Brunei’s Ministry of Health and Healthcare Global Enterprises.

The market is at the forefront of revolutionizing healthcare and biological research, driven by advancements in nucleic acid sequencing and molecular biology. It plays a crucial role in understanding disease transmission chains and implementing effective public health control and containment measures. Through the analysis of RNA and identification of disease biomarkers, bioinformatics enables the development of innovative therapeutic strategies. Big data analysis techniques are employed for comprehensive genomic and proteomic research, facilitating drug development and gene therapy. Organizations like Strand Life Sciences and ATCC contribute significantly to database development and the provision of biological materials, including animal and human cell lines. Foundations like the Gates and Melinda Foundation support initiatives aimed at leveraging bioinformatics for global health improvements.

The market is witnessing remarkable growth, fueled by the demand for personalized medicine and advancements in clinical diagnostics. As biotechnology and pharmaceutical industries continue to innovate, companies like NeoGenomics Laboratories, Partek Incorporated, and SOPHiA Genetics are leading the charge with cutting-edge solutions such as HostSeq and VirusSeq. However, concerns over patient data confidentiality persist, driving the need for robust security measures. Amidst the pandemic (SARS-CoV-2), bioinformatics plays a pivotal role in deciphering the virus's genetic code and developing effective diagnostic tools. With continuous technological advancements and product innovations, the bioinformatics sector is poised for further expansion and impact on global healthcare.

Segment Overview

The market analysis and report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Application Outlook 
    • Molecular phylogenetics
    • Transcriptomic
    • Proteomics
    • Metabolomics
  • Product Outlook 
    • Platforms
    • Tools
    • Services
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World
      • Saudi Arabia
      • South Africa
      • Rest of the Middle East & Africa

 

Bioinformatics Market Scope

Report Coverage

Details

Page number

170

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 13%

Market growth 2023-2027

USD 8.53 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

12.86

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 44%

Key countries

US, Canada, Germany, UK, and France

Competitive landscape

 Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks

Key companies profiled

Agilent Technologies Inc., Azenta Inc., Bio Rad Laboratories Inc., Biomax Informatics AG, DNASTAR Inc., Eurofins Scientific SE, Fios Genomics Ltd., Genedata AG, Geneva Bioinformatics SA, Illumina Inc., Partek Inc., Perkin Elmer Inc., Precigen Inc., QIAGEN NV, Quest Diagnostics Inc., Seven Bridges Genomics Inc., Source BioScience, Thermo Fisher Scientific Inc., Waters Corp., and ZS Associates Inc.

Market dynamics

Parent market analysis, Market growth and trends and inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period.

Customization purview

If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the size of the market  size and its contribution to the market with a  focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behaviour
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global bioinformatics market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global bioinformatics market 2017 - 2021 ($ million)
    • 4.2 Application Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.3 Product Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
    • 6.2 Comparison by Application
      • Exhibit 32: Chart on Comparison by Application
      • Exhibit 33: Data Table on Comparison by Application
    • 6.3 Molecular phylogenetics - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Molecular phylogenetics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Molecular phylogenetics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Molecular phylogenetics - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Molecular phylogenetics - Year-over-year growth 2022-2027 (%)
    • 6.4 Transcriptomic - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Transcriptomic - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Transcriptomic - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Transcriptomic - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Transcriptomic - Year-over-year growth 2022-2027 (%)
    • 6.5 Proteomics - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Proteomics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Proteomics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Proteomics - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Proteomics - Year-over-year growth 2022-2027 (%)
    • 6.6 Metabolomics - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Metabolomics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 47: Data Table on Metabolomics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Chart on Metabolomics - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Metabolomics - Year-over-year growth 2022-2027 (%)
    • 6.7 Market opportunity by Application
      • Exhibit 50: Market opportunity by Application ($ million)
      • Exhibit 51: Data Table on Market opportunity by Application ($ million)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 52: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 53: Data Table on Product - Market share 2022-2027 (%)
    • 7.2 Comparison by Product
      • Exhibit 54: Chart on Comparison by Product
      • Exhibit 55: Data Table on Comparison by Product
    • 7.3 Platforms - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Platforms - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Platforms - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Platforms - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Platforms - Year-over-year growth 2022-2027 (%)
    • 7.4 Tools - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Tools - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Tools - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Tools - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Tools - Year-over-year growth 2022-2027 (%)
    • 7.5 Services - Market size and forecast 2022-2027
      • Exhibit 64: Chart on Services - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Data Table on Services - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Chart on Services - Year-over-year growth 2022-2027 (%)
      • Exhibit 67: Data Table on Services - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Product
      • Exhibit 68: Market opportunity by Product ($ million)
      • Exhibit 69: Data Table on Market opportunity by Product ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 71: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 72: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 73: Chart on Geographic comparison
      • Exhibit 74: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 UK - Market size and forecast 2022-2027
      • Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.10 Canada - Market size and forecast 2022-2027
      • Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.11 France - Market size and forecast 2022-2027
      • Exhibit 107: Chart on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 108: Data Table on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 111: Market opportunity by geography ($ million)
      • Exhibit 112: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 113: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 115: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 116: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 117: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 118: Matrix on vendor position and classification
            • 12.3 Agilent Technologies Inc.
              • Exhibit 119: Agilent Technologies Inc. - Overview
              • Exhibit 120: Agilent Technologies Inc. - Business segments
              • Exhibit 121: Agilent Technologies Inc. - Key offerings
              • Exhibit 122: Agilent Technologies Inc. - Segment focus
            • 12.4 Azenta Inc.
              • Exhibit 123: Azenta Inc. - Overview
              • Exhibit 124: Azenta Inc. - Business segments
              • Exhibit 125: Azenta Inc. - Key offerings
              • Exhibit 126: Azenta Inc. - Segment focus
            • 12.5 Bio Rad Laboratories Inc.
              • Exhibit 127: Bio Rad Laboratories Inc. - Overview
              • Exhibit 128: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 129: Bio Rad Laboratories Inc. - Key news
              • Exhibit 130: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 131: Bio Rad Laboratories Inc. - Segment focus
            • 12.6 DNASTAR Inc.
              • Exhibit 132: DNASTAR Inc. - Overview
              • Exhibit 133: DNASTAR Inc. - Product / Service
              • Exhibit 134: DNASTAR Inc. - Key offerings
            • 12.7 Eurofins Scientific SE
              • Exhibit 135: Eurofins Scientific SE - Overview
              • Exhibit 136: Eurofins Scientific SE - Business segments
              • Exhibit 137: Eurofins Scientific SE - Key news
              • Exhibit 138: Eurofins Scientific SE - Key offerings
              • Exhibit 139: Eurofins Scientific SE - Segment focus
            • 12.8 Fios Genomics Ltd.
              • Exhibit 140: Fios Genomics Ltd. - Overview
              • Exhibit 141: Fios Genomics Ltd. - Product / Service
              • Exhibit 142: Fios Genomics Ltd. - Key offerings
            • 12.9 Geneva Bioinformatics SA
              • Exhibit 143: Geneva Bioinformatics SA - Overview
              • Exhibit 144: Geneva Bioinformatics SA - Product / Service
              • Exhibit 145: Geneva Bioinformatics SA - Key offerings
            • 12.10 Illumina Inc.
              • Exhibit 146: Illumina Inc. - Overview
              • Exhibit 147: Illumina Inc. - Business segments
              • Exhibit 148: Illumina Inc. - Key news
              • Exhibit 149: Illumina Inc. - Key offerings
              • Exhibit 150: Illumina Inc. - Segment focus
            • 12.11 Partek Inc.
              • Exhibit 151: Partek Inc. - Overview
              • Exhibit 152: Partek Inc. - Product / Service
              • Exhibit 153: Partek Inc. - Key offerings
            • 12.12 Perkin Elmer Inc.
              • Exhibit 154: Perkin Elmer Inc. - Overview
              • Exhibit 155: Perkin Elmer Inc. - Business segments
              • Exhibit 156: Perkin Elmer Inc. - Key news
              • Exhibit 157: Perkin Elmer Inc. - Key offerings
              • Exhibit 158: Perkin Elmer Inc. - Segment focus
            • 12.13 QIAGEN NV
              • Exhibit 159: QIAGEN NV - Overview
              • Exhibit 160: QIAGEN NV - Product / Service
              • Exhibit 161: QIAGEN NV - Key news
              • Exhibit 162: QIAGEN NV - Key offerings
            • 12.14 Quest Diagnostics Inc.
              • Exhibit 163: Quest Diagnostics Inc. - Overview
              • Exhibit 164: Quest Diagnostics Inc. - Business segments
              • Exhibit 165: Quest Diagnostics Inc. - Key offerings
              • Exhibit 166: Quest Diagnostics Inc. - Segment focus
            • 12.15 Thermo Fisher Scientific Inc.
              • Exhibit 167: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 168: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 169: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 170: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 171: Thermo Fisher Scientific Inc. - Segment focus
            • 12.16 Waters Corp.
              • Exhibit 172: Waters Corp. - Overview
              • Exhibit 173: Waters Corp. - Business segments
              • Exhibit 174: Waters Corp. - Key news
              • Exhibit 175: Waters Corp. - Key offerings
              • Exhibit 176: Waters Corp. - Segment focus
            • 12.17 ZS Associates Inc.
              • Exhibit 177: ZS Associates Inc. - Overview
              • Exhibit 178: ZS Associates Inc. - Product / Service
              • Exhibit 179: ZS Associates Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 180: Inclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 181: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 182: Research methodology
                • Exhibit 183: Validation techniques employed for market sizing
                • Exhibit 184: Information sources
              • 13.5 List of abbreviations
                • Exhibit 185: List of abbreviations
              • growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
                • product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.

                  Research Framework

                  Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                  INFORMATION SOURCES

                  Primary sources

                  • Manufacturers and suppliers
                  • Channel partners
                  • Industry experts
                  • Strategic decision makers

                  Secondary sources

                  • Industry journals and periodicals
                  • Government data
                  • Financial reports of key industry players
                  • Historical data
                  • Press releases

                  DATA ANALYSIS

                  Data Synthesis

                  • Collation of data
                  • Estimation of key figures
                  • Analysis of derived insights

                  Data Validation

                  • Triangulation with data models
                  • Reference against proprietary databases
                  • Corroboration with industry experts

                  REPORT WRITING

                  Qualitative

                  • Market drivers
                  • Market challenges
                  • Market trends
                  • Five forces analysis

                  Quantitative

                  • Market size and forecast
                  • Market segmentation
                  • Geographical insights
                  • Competitive landscape

                  PURCHASE FULL REPORT OF

                  bioinformatics market market

                  QUICK BUY

                  Key Questions Answered

                  • What are the key global market and the regional market share?
                  • What are the revenue-generating key market segments?
                  • What are the key factors driving and challenging this market’s growth?
                  • Who are the key market vendors and their growth strategies?
                  • What are the latest trends influencing the growth of this market?
                  • What are the variables influencing the market growth in the primary regions?
                  • What are the factors influencing the growth of the parent market?

                  Why should you prefer Technavio's market insights report?

                  • Off-the-shelf research reports
                  • Reports can be tailored to meet the customer's needs
                  • Trusted by more than 100 fortune 500 organizations
                  • Information about the market's key drivers, trends, and challenges
                  • Parent market analysis
                  • Every week, 50,000 people visit our subscription platform
                  • Detailed vendors report with competitive landscape
                  • Covid-19 impact and recovery analysis
                  • Data on revenue-generating market segments
                  • Details on the market shares of various regions
                  • Five-force market analysis